These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33065725

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Portopulmonary hypertension.
    Cartin-Ceba R, Krowka MJ.
    Clin Liver Dis; 2014 May; 18(2):421-38. PubMed ID: 24679504
    [Abstract] [Full Text] [Related]

  • 25. Predictors of survival in portopulmonary hypertension: a 20-year experience.
    Aggarwal M, Li M, Bhardwaj A, Wallace WD, Wang X, Carey WD, Dweik RA, Heresi GA, Tonelli AR.
    Eur J Gastroenterol Hepatol; 2022 Apr 01; 34(4):449-456. PubMed ID: 34907982
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
    Raevens S, Geerts A, Devisscher L, Van Vlierberghe H, Van Steenkiste C, Colle I.
    Acta Gastroenterol Belg; 2021 Apr 01; 84(1):95-99. PubMed ID: 33639700
    [Abstract] [Full Text] [Related]

  • 28. Early initiation of prostacyclin in portopulmonary hypertension: 10 years of a transplant center's experience.
    Awdish RL, Cajigas HR.
    Lung; 2013 Dec 01; 191(6):593-600. PubMed ID: 23979006
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.
    Hollatz TJ, Musat A, Westphal S, Decker C, D'Alessandro AM, Keevil J, Zhanhai L, Runo JR.
    Liver Transpl; 2012 Jun 01; 18(6):686-95. PubMed ID: 22315210
    [Abstract] [Full Text] [Related]

  • 33. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes.
    Del Valle KT, Krowka MJ, Heimbach JK, Taner T, DuBrock HM.
    Transplant Direct; 2022 Dec 01; 8(12):e1410. PubMed ID: 36398194
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival.
    Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ.
    Liver Transpl; 2015 Nov 01; 21(11):1355-64. PubMed ID: 26077312
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.